Discontinued — last reported Q4 '22
Business Segments · CapEx
Specialty Diagnostics — CapEx
Thermo Fisher Scientific Specialty Diagnostics — CapEx remained flat by 0.0% to $28.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 32.9%, from $41.75M to $28.00M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2022
How to read this metric
Higher spending indicates investment in future growth and capacity, while lower spending may signal a focus on cash preservation or a mature asset base.
Detailed definition
This metric measures the cash outflows used by the Specialty Diagnostics segment to acquire, upgrade, and maintain physi...
Peer comparison
Comparable to capital expenditure (CapEx) figures across the broader medical device and diagnostics industry.
Metric ID:
tmo_segment_specialty_diagnostics_capital_expendituresHistorical Data
2 years
| FY'21 | FY'22 | |
|---|---|---|
| Value | $167.00M | $112.00M |
| YoY Change | — | -32.9% |
Range$112.00M – $167.00M
Avg YoY Growth-32.9%
Median YoY Growth-32.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's specialty diagnostics — capex?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — capex of $28.00M in Q4 2022.
- How has Thermo Fisher Scientific's specialty diagnostics — capex changed year-over-year?
- Thermo Fisher Scientific's specialty diagnostics — capex decreased by 32.9% year-over-year, from $41.75M to $28.00M.
- What does specialty diagnostics — capex mean?
- The amount of money spent by the segment to acquire or maintain physical assets like machinery and facilities.